Home Jounce Therapeutics

Jounce Therapeutics

In operation
IPO
Developer of New Drugs for Immunotherapy
Basic
Enterprise Profile

Basic Information

Jounce Therapeutics is a clinical-stage immunotherapy company dedicated to transforming cancer treatment by developing therapies that enable the immune system to attack tumors and provide lasting benefits to patients through a biomarker-driven approach.
Jounce Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
101~500 people
January 01, 2013
kjoshi@jouncetx.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Targeted Technology Immunological Techniques
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs Monoclonal Antibody